Home
Home

diabetic macular edema

Alimera Sciences announces first patient treated with Iluvien

Alimera Sciences announces first patient treated with Iluvien
Yahoo/Fly on the Wall

For Iluvien, The FDA Isn't The Issue; European Sales Are

For Iluvien, The FDA Isn't The Issue; European Sales Are
Seeking Alpha

Ampio's Eye Drug Trial Design Won't Pass FDA Muster

Ampio's Eye Drug Trial Design Won't Pass FDA Muster
TheStreet.com

Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia

Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Yahoo

Alimera Sciences: A Sleeping Giant

Alimera Sciences: A Sleeping Giant
Seeking Alpha

Novartis’s Lucentis Wins U.K. Backing as Drug’s Price Cut

Novartis’s Lucentis Wins U.K. Backing as Drug’s Price Cut
Bloomberg

1 Pharma Receiving Nice News (NVS)

1 Pharma Receiving Nice News (NVS)
Motley Fool

NICE reverses position on new use for Novartis' Lucentis

NICE reverses position on new use for Novartis' Lucentis
Fierce Pharma

FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)

FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Pipeline Review

Roche’s Lucentis Works To Treat Vision Loss From Diabetes

Roche’s Lucentis Works To Treat Vision Loss From Diabetes
Bloomberg